Ultrapure Water Treatment Companies
Ultrapure water system providers for semiconductor, power, and life-sciences, multi-stage RO, EDI, and polishing loops.
14 specialist providers · 7 countries
Qualified suppliers come to you.
Filter results
Country
Industry
Technology
Not sure where to start?
Showing 1-14 of 14
Specialists in ultrapure water treatment
Providers whose services or self-declared specialties match this category.
Guangzhou Globaluf Water Treatment Co., Ltd.
VerifiedChina · 1-50 employees
Guangzhou Globaluf Water Treatment Co., Ltd. is a water treatment equipment manufacturer in Guangzhou, China, since 2005. We design and build skid-mounted and containerized SWRO seawater desalination systems, brackish water RO plants, ultrafiltration (UF) membrane systems, EDI ultrapure water units, MBR wastewater treatment systems and bottled water filling lines, and supply membranes, housings and consumables to customers worldwide.
Buyer's guide
The buyer's guide to ultrapure water treatment
Ultrapure Water Production: Ion Exchange, EDI, and Resistivity Standards for Semiconductor and Pharma
Ultrapure water (UPW) is water purified to extremely high quality standards required in semiconductor manufacturing, pharmaceutical production, power generation (nuclear and fossil fuel), and analytical laboratory applications. UPW quality targets vary by application: semiconductor UPW (SEMI F63 standard): resistivity 18.2 MOhm.cm (conductivity 0.055 uS/cm); TOC less than 1 ppb; particles less than 50 nm at less than 0.5 particles/mL; bacteria less than 0.001 CFU/mL; dissolved silica less than 0.1 ppb; dissolved oxygen less than 1 ppb.
Pharmaceutical purified water (USP/BP monograph): conductivity less than 1.3 uS/cm at 25 degrees C; TOC less than 500 ppb; bacteria less than 100 CFU/mL; WFI (Water For Injection) standards are more stringent: conductivity less than 1.1 uS/cm, bacteria less than 0.1 CFU/mL, endotoxins less than 0.25 EU/mL. Power plant boiler makeup water: conductivity less than 0.1 uS/cm; SiO2 less than 0.01 mg/L; cations as Na+ less than 2 ppb. Analytical/HPLC water: ASTM D1193 Type 1 (resistivity 18.2 MOhm.cm), Type 2 (1 MOhm.cm), Type 3 (0.05 MOhm.cm).
UPW production treatment train for semiconductor manufacturing: (1) Pretreatment: ultrafiltration (UF) or multimedia filtration removes particulate; activated carbon removes chlorine (protects downstream IX resin); (2) Primary purification: RO (first pass, 98 to 99.5 percent ion rejection); CO2 degassing (membrane contactor, removes carbonic acid before IX); two-bed or mixed-bed ion exchange (removes remaining ions to conductivity less than 0.1 uS/cm); (3) Secondary purification: electrodeionisation (EDI, continuous regeneration, achieves 0.06 uS/cm); UV oxidation (185 nm UV destroys TOC to ppb levels; 254 nm UV disinfects); UF polishing (hollow fibre, 0.01 micron, removes particles and bacteria); (4) Point-of-use (POU): final 0.01 to 0.05 micron UF filter at each tool connection; nitrogen blanket on tanks to prevent CO2 dissolution (which would increase conductivity).
Loop design: UPW distributed in a closed loop (not dead-end); continuous recirculation (flow velocity greater than 0.3 m/s in PVDF or electropolished SS distribution piping) prevents biofilm growth and particle settling. Loop monitoring: inline resistivity (18.2 MOhm.cm target); online TOC (less than 1 ppb); online particle counter (greater than 0.05 micron).
Pharmaceutical UPW: USP Purified Water and WFI (Water for Injection) are the two main monograph-defined pharmaceutical water grades. Purified water generation: RO (single or double pass) + CDI (continuous deionisation) or mixed-bed DI + UV (254 nm, 40 mJ/cm2) + 0.22 micron final filter. WFI generation: historically required distillation (multi-effect still, MES, or vapour compression still, VCS) - EU/USP requirement for WFI until 2017 Ph. Eur. revision; now membrane-based WFI generation is accepted in EU (Ph. Eur. 8th edition, 2017): double-pass RO + UF (0.01 micron) at greater than 70 degrees C (hot loop to prevent biofilm). Hot UPW loops at 70 to 80 degrees C for pharmaceutical WFI are effective Legionella control measures (HTST principle within loop). UPW equipment is available from the established global suppliers, with dedicated laboratory-scale systems for analytical use. UPW system validation: GAMP5 and 21 CFR Part 11 (FDA) for pharmaceutical UPW; SEMI documentation for semiconductor.
Frequently asked questions
What resistivity does ultrapure water need to achieve?
Resistivity requirements for UPW by application: Semiconductor manufacturing (SEMI F63:2009 standard): 18.2 MOhm.cm (maximum possible resistivity, thermodynamic limit of pure water at 25 degrees C from autoionisation H2O yields H+ + OH-); this corresponds to conductivity of 0.055 uS/cm (55 nS/cm); at this purity, even CO2 dissolved from room air at 400 ppm would reduce resistivity to approximately 1 MOhm.cm - distribution loops must use nitrogen blanket or PVDF closed-loop recirculation. Power plant boiler makeup (high-pressure supercritical boilers, greater than 250 bar): resistivity greater than 10 MOhm.cm; conductivity less than 0.1 uS/cm; SiO2 less than 10 ppb. Analytical HPLC water (ASTM D1193): Type 1 (trace metals and organic analysis): 18.2 MOhm.cm; TOC less than 10 ppb; Type 2 (general analytical): 1 MOhm.cm; Type 3 (feedwater for Type 1/2 stills): 0.05 MOhm.cm. Pharmaceutical purified water (USP/Ph. Eur.): conductivity less than 1.3 uS/cm (0.77 MOhm.cm); not equivalent to semiconductor UPW. WFI: conductivity less than 1.1 uS/cm at 25 degrees C. Practical measurement: inline resistivity monitors from the established instrument manufacturers measure at the point of use; temperature compensation to 25 degrees C is essential (resistivity decreases 2 percent per degree C).
What is electrodeionisation (EDI) and how does it produce UPW?
Electrodeionisation (EDI) is a continuous ion removal process that combines ion exchange resin with ion-selective membranes and an applied DC electrical field to simultaneously demineralise water and regenerate the resin electrically, without chemical regeneration. EDI module construction: alternating dilute (process water) and concentrate compartments; dilute compartments filled with mixed ion exchange resin beads; cation exchange membranes allow only cations to pass through; anion exchange membranes allow only anions; DC voltage (50 to 600V) drives ion migration: cations migrate through cation membranes to concentrate; anions through anion membranes to concentrate; water splitting at resin interfaces (H2O yields H+ + OH-) continuously regenerates resin. Product water: conductivity 0.06 to 0.1 uS/cm (approximately 10 to 16 MOhm.cm resistivity); SiO2 less than 1 ppb; TOC 10 to 50 ppb (from resin leachate, decreasing with operation time). EDI advantages over chemical mixed-bed IX: no chemical regenerant (no acid/caustic); continuous operation (vs batch regeneration for IX); lower operating hazard; generates smaller waste volume. EDI requires: RO permeate feed (less than 0.5 mg/L hardness, less than 1 mg/L CO2); carbon dioxide must be removed before EDI (CO2 consumes electrical energy); EDI operates on CO2-free RO permeate to achieve rated performance. EDI modules are available from the established manufacturers.
What materials are used for ultrapure water distribution piping?
UPW distribution piping must not leach ions, organics, or particles into the ultra-high-purity water. Material selection: (1) PVDF (polyvinylidene fluoride): the gold standard for semiconductor UPW; extremely low leachable content; does not leach plasticisers, stabilisers, or metal ions; smooth bore (Ra less than 0.4 micron); chemical resistance to all common UPW cleaning agents; electrofusion or butt-fusion welding; maximum temperature 140 degrees C; SEMI-certified PVDF grades; cost: approximately 5 to 10 times PVC per metre installed; (2) Electropolished 316L stainless steel: for pharmaceutical hot WFI loops (70 to 85 degrees C); surface roughness Ra less than 0.5 micron (electropolished); cleaned and passivated per ASME BPE or EHEDG standards; less prone to biofilm than plastic at elevated temperature; (3) High-purity polypropylene (PP): lower quality than PVDF; used for non-critical UPW secondary loops and drain lines; lower cost; adequate for purified water loops not requiring semi-conductor grade; (4) PFA (perfluoroalkoxy alkane): fluoropolymer with even lower extractables than PVDF; used for point-of-use connections to semiconductor tools; extremely inert; high cost. Avoid: PVC (contains plasticisers and stabilisers that leach); copper (leaches Cu2+ ions at sub-ppb levels, unacceptable for semiconductor); standard stainless steel without electropolishing (high Ra, particle shedding).
How is UPW water quality monitored in real time?
Online UPW quality monitoring is essential for semiconductor and pharmaceutical applications where off-specification water reaching a critical process causes expensive product rejection. Key online monitors: (1) Resistivity/conductivity: inline resistivity monitors at each distribution loop return and point-of-use; 18.2 MOhm.cm target; alarm at less than 17 MOhm.cm (semiconductor); monitoring frequency: continuous (second-by-second logging); (2) TOC (Total Organic Carbon): online UV-persulphate or UV-combustion TOC analysers; detection limit 0.05 ppb C; alarm at 2 to 10 ppb TOC; sample frequency: 1 to 5 minutes per point; (3) Dissolved oxygen (DO): optical DO sensors; target less than 1 ppb DO in semiconductor UPW (prevents copper oxidation in wafer fab tools); membrane-covered amperometric or luminescent quenching sensor; (4) Particle counting: inline laser particle counters; count particles greater than 50 nm in 1 mL sample volume; alarm at greater than 0.5 particles/mL for 50 nm; (5) Viable bacteria: online rapid microbiology (bioluminescence ATP); traditional grab sample culture still required for US FDA 21 CFR and Ph. Eur. validation. Data management: all UPW monitors feed into facility management system (FMS) or SCADA; continuous archiving; statistical process control (SPC) charting; automated shutdown if out-of-spec water detected before reaching critical process tools.
Illustrative scenario · Pharmaceutical manufacturing, Cambridgeshire
A composite drawn from typical projects in this category, not a single client engagement. Figures are indicative.
- Challenge
- A biopharmaceutical facility in Cambridgeshire needed to upgrade its Purified Water (PW) system to supply 12 m3/h for buffer preparation and equipment cleaning, and to generate 3 m3/h of Water for Injection (WFI) for aseptic manufacturing. The existing system was a single-pass RO with chemical regeneration mixed-bed DI; it had failed three USP Purified Water conductivity tests in 18 months and the facility had received an FDA 483 observation on WFI generation method and monitoring.
- Approach
- The system was redesigned as: double-pass RO (first pass 80 percent recovery, second pass 85 percent) followed by electrodeionisation (EDI), UV TOC oxidation (185 nm), and 0.22 micron final filtration for PW. WFI was generated by a dedicated hot loop: PW passed through a UF membrane (0.01 micron PVDF, 70 degrees C loop), maintained at 80 degrees C throughout a sanitised 316L SS distribution loop with electropolished internal surface (Ra less than 0.5 micron). All system components were IQ/OQ/PQ validated per GAMP5. USP Purified Water conductivity less than 1.3 uS/cm and WFI endotoxin less than 0.25 EU/mL demonstrated during commissioning.
- Outcome
- USP and Ph. Eur. compliance achieved and maintained over 24 months of production. FDA 483 observation resolved at next inspection. System availability 99.2 percent. TOC consistently less than 20 ppb (specification less than 500 ppb for PW). The UF-based membrane WFI system cost GBP 180,000 versus GBP 420,000 for a multi-effect still of equivalent capacity, a GBP 240,000 capital saving.
Questions to ask shortlisted providers
5
- 01
What USP, Ph. Eur., or SEMI standard does this system meet, and does the supplier have GMP documentation (GAMP5 design qualification, IQ/OQ/PQ protocols) ready for regulatory submission?
Pharmaceutical UPW systems require full IQ/OQ/PQ validation documentation for FDA and MHRA submissions; systems without pre-prepared validation protocols add 3 to 6 months to commissioning timelines.
- 02
For WFI systems, is the proposed generation method accepted by both the FDA (21 CFR Part 211.68) and the EU/UK (Ph. Eur. 0169 and BS EN 2005)?
EU Ph. Eur. permits membrane-based WFI since 2017; FDA since 2024; some legacy regulatory expectations still favour distillation; confirming acceptance in your specific regulatory jurisdiction before capital commitment is essential.
- 03
What is the biofilm control strategy for the UPW distribution loop, and how frequently is the loop sanitised?
UPW loops support biofilm growth despite their purity; hot loop maintenance at 70 to 80 degrees C or periodic chemical/heat sanitisation (cold loops) is critical; loops without a defined sanitisation programme will fail microbial counts within months.
- 04
What is the resistivity and TOC guarantee at the point of use (not at the system outlet), and how is point-of-use quality verified?
UPW quality degrades through the distribution loop; carbon dioxide ingress, particle shedding from fittings, and dead-leg stagnation all reduce quality from outlet to point of use; the point-of-use specification must be contractually guaranteed, not just the system outlet.
- 05
How are the EDI or mixed-bed DI modules replaced or regenerated, and what is the expected chemical waste volume per regeneration cycle?
Chemical mixed-bed DI regeneration produces acidic and caustic waste streams requiring neutralisation and trade effluent consent; EDI eliminates chemical regeneration but requires feed conductivity less than 40 uS/cm from RO.
What drives cost in this category
4
- WFI generation method (distillation vs membrane)
- Multi-effect still (WFI by distillation): GBP 350,000 to 800,000 capital for 2 to 5 m3/h; UF-based membrane WFI (Ph. Eur. accepted): GBP 150,000 to 350,000 capital; ongoing steam cost for still: GBP 20 to 50 per m3 WFI; UF membrane system uses electricity at GBP 0.10 to 0.20 per m3.
- Validation and documentation scope
- GAMP5 IQ/OQ/PQ validation for a pharmaceutical UPW system adds GBP 40,000 to 150,000 to project cost; FDA 21 CFR Part 11 compliant data logging systems add GBP 15,000 to 50,000; these costs are non-optional for GMP facility installations.
- Distribution loop material and fabrication standard
- 316L stainless steel electropolished loop (Ra less than 0.5 micron, orbital welded) costs GBP 150 to 350 per metre installed; PVDF loop (Ra less than 0.4 micron, electrofusion welded) costs GBP 100 to 250 per metre but cannot be heat-sanitised above 80 degrees C.
- Online monitoring instrumentation
- Resistivity, TOC, DO, and particle count monitoring at 10 to 20 loop sample points costs GBP 80,000 to 200,000 for pharmaceutical-grade instrument quality; instruments must be ISO/IEC 17025 calibrated and traceable to national standards.
Key regulations and standards
4
- Ph. Eur. (European Pharmacopoeia) 0169 and 0169/5
- Ph. Eur. monographs for Purified Water (0169) and Water for Injections (0169/5): conductivity limits (PW less than 1.3 uS/cm at 25 degrees C; WFI less than 1.1 uS/cm), TOC less than 500 ppb, bacteria less than 100 CFU/mL for PW and less than 0.1 CFU/mL for WFI; endotoxin less than 0.25 EU/mL for WFI. Membrane-based WFI accepted since 8th edition (2017) for EU.
- FDA 21 CFR Part 211.68 and USP Purified Water
- US FDA 21 CFR Part 211.68: requires that drug manufacturing systems use purified water meeting USP specifications; USP Purified Water (USP <1231>): conductivity less than 1.3 uS/cm, TOC less than 500 ppb, bacteria less than 100 CFU/mL. FDA accepts membrane WFI from 2024 under revised FDA Water for Pharmaceuticals guidance.
- SEMI F63 and F29 for Semiconductor UPW
- SEMI F63: semiconductor UPW specification covering resistivity (18.2 MOhm.cm), TOC (less than 1 ppb), particles (less than 50 nm, less than 0.5/mL), bacteria (less than 0.001 CFU/mL), dissolved oxygen (less than 1 ppb), dissolved silica (less than 0.1 ppb). SEMI F29: specification for monitoring of UPW quality in semiconductor fabs.
- GAMP5 and MHRA Data Integrity Guidance
- ISPE GAMP5 (Good Automated Manufacturing Practice): GMP guidance for pharmaceutical computer systems validation; MHRA Data Integrity Guidance (2018): 21 CFR Part 11-equivalent requirements for UK pharmaceutical data recording; UPW SCADA and data historian systems must comply for MHRA-licensed facilities.
From the Insider